CARLSMED (CARL) COO Jeffrey Bertolini Receives 50,000-Option Award

What Happened
Jeffrey Bertolini, Chief Operating Officer of Carlsmed, was granted a derivative award of 50,000 stock options (reported as 50,000 shares @ $0.00) on 2026-09-08. The Form 4 (filed 2026-09-10) records this as an award/grant (code A); no cash payment is reported in the filing. This is a compensation grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-08; Form 4 filed: 2026-09-10 (appears timely—within the usual 2 business-day window).
• Reported security: 50,000 derivative units (stock options exercisable into ≈50,000 common shares).
• Reported price: $0.00 (grant reported with no cash paid).
• Vesting (per footnote F1): vesting began 9/8/2026, subject to a one‑year cliff, then vests in equal installments each quarterly anniversary thereafter, contingent on continued service.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnote: F1 describes the options and vesting schedule; exercise price/valuation not specified in this Form 4.

Context
These are stock option awards, which convert to actual shares only after vesting and exercise; they do not represent immediate share purchases or sales. Option grants are common executive compensation and should be interpreted as part of pay/incentive, not a direct buy/sell signal. For full economic terms (exercise price, valuation, tax treatment) check related 8-K, proxy, or company disclosures.